Skip to main content
Premium Trial:

Request an Annual Quote

Bristol-Myers Squibb to Use Sequenom s MassArray Tech to Investigate Disease Targets

NEW YORK, July 10 - Bristol-Myers Squibb will use Sequenom's MassArray technology and DNA sample library to evaluate specific undisclosed disease targets, Sequenom said.


The genotyping company said it will receive milestone payments and royalties on products that result from the collaboration.